共 74 条
[1]
El-Serag HB(2007)Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2557-2576
[2]
Rudolph KL(2010)Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis Eur J Cancer 46 744-751
[3]
Kuo YH(2002)Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164-1171
[4]
Lu SN(2002)Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet. 359 1734-1759
[5]
Chen CL(2006)Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients Gastroenterology 131 461-469
[6]
Lo CM(1996)Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization Radiology 198 33-40
[7]
Ngan H(2005)Management of hepatocellular carcinoma Hepatology 42 1208-1236
[8]
Tso WK(2007)Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk J Vasc Interv Radiol 18 1517-26
[9]
Llovet JM(2009)Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion J Gastroenterol Hepatol 24 806-814
[10]
Real MI(1997)The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study Cancer 79 2087-94